Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences to Present at the Deutsche Bank Health Care and the Bank of America Merrill Lynch Health Care Conferences
PLAINSBORO, N.J., April 28, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in May as follows: On Monday, May 2, 2011 at 1:30 PM ET., Mr. Brian Larkin, President, Global Spine and Orthobiologics and Head of
View HTML
Toggle Summary Integra LifeSciences CFO Jack Henneman Selected as a 2011 SmartCXO Winner by Philadelphia SmartCEO Magazine
PLAINSBORO, N.J., April 18, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced that John B. Henneman, III, Integra's Executive Vice President, Finance and Administration, and Chief Financial Officer, has been selected as one of ten winners in the Chief
View HTML
Toggle Summary Integra LifeSciences Announces Instrument Repair Partnership With InstruMedics
PLAINSBORO, N.J., April 14, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp (Nasdaq:IART) today announced a partnership with InstruMedics LLC., a national provider of service and repair for surgical instruments and equipment. The relationship will allow Integra's Surgical Instrument
View HTML
Toggle Summary Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3(R) Demineralized Bone Matrix
PLAINSBORO, N.J., April 12, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market Accell Evo3 ® Demineralized Bone Matrix as a bone void filler
View HTML
Toggle Summary Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices
PLAINSBORO, N.J., April 11, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received 510k clearance from the United States Food and Drug Administration (FDA) for three new spinal intervertebral body fusion devices (IBD), continuing to
View HTML
Toggle Summary Integra LifeSciences Opens New Facility in Medina, Ohio
PLAINSBORO, N.J., April 8, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has opened a new facility in Medina, Ohio, to house its growing spinal implant business. The facility is equipped with the latest video and communication technology,
View HTML
Toggle Summary Integra LifeSciences to Host Its First Quarter 2011 Earnings Results Conference Call on April 28, 2011
PLAINSBORO, N.J., April 5, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2011 financial results on Thursday, April 28, 2011. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
View HTML
Toggle Summary Integra LifeSciences Announces Three-Year Contract With Novation to Provide Jarit(R) Sterilization Containers
PLAINSBORO, N.J., April 4, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract with Novation, the leading healthcare supply contracting company, to provide Jarit® sterilization containers to the members of VHA
View HTML
Toggle Summary Integra LifeSciences Features the Integra(TM) Endoscopic Gastroc Release System (EGR) Product Line at the Annual ACFAS Meeting
PLAINSBORO, N.J., March 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is featuring the Integra(TM) Endoscopic Gastroc Release System (EGR) product line at the Annual Meeting of the American College of Foot and Ankle Surgeons (ACFAS) on
View HTML
Toggle Summary Integra LifeSciences to Present at the Following Four Conferences in March:
Citi Global Healthcare Conference RBC Capital Markets' Healthcare Conference Raymond James' Institutional Investors Conference Barclays Capital Global Healthcare Conference   PLAINSBORO, N.J., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today
View HTML